Scott Haake Archives
Grant to support Haake’s research on kidney cancer
Feb. 17, 2022—Kure It Cancer Research has awarded a $200,000 grant to support kidney cancer research by Vanderbilt's Scott Haake, MD.
Analysis reveals macrophages associated with kidney cancer recurrence
May. 24, 2021—A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development.